These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12149963)

  • 21. Simulating dissolution of intravitreal triamcinolone acetonide suspensions in an anatomically accurate rabbit eye model.
    Missel PJ; Horner M; Muralikrishnan R
    Pharm Res; 2010 Aug; 27(8):1530-46. PubMed ID: 20467888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution of weak acids under laminar flow and rotating disk hydrodynamic conditions: application of a comprehensive convection-diffusion-migration-reaction transport model.
    Neervannan S; Southard MZ; Stella VJ
    J Pharm Sci; 2012 Sep; 101(9):3180-9. PubMed ID: 22623113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
    Macheras P; Iliadis A; Melagraki G
    Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental determination of the diffusion boundary layer width of micron and submicron particles.
    Galli C
    Int J Pharm; 2006 Apr; 313(1-2):114-22. PubMed ID: 16529883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissolution-controlled transport from dispersed matrixes.
    Chandrasekaran SK; Paul DR
    J Pharm Sci; 1982 Dec; 71(12):1399-402. PubMed ID: 7153891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simulation of the mobility of metal-EDTA complexes in groundwater: the influence of contaminant metals.
    Friedly JC; Kent DB; Davis JA
    Environ Sci Technol; 2002 Feb; 36(3):355-63. PubMed ID: 11871549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of dissolution and diffusion-controlled drug release systems.
    Simon L; Bolisetty P; Erazo MN
    Curr Drug Deliv; 2011 Mar; 8(2):144-51. PubMed ID: 21235474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular devices for the controlled systemic delivery of insulin: in vitro and in vivo dissolution.
    Lee YC; Yalkowsky SH
    Int J Pharm; 1999 Apr; 181(1):71-7. PubMed ID: 10370204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of fluid velocity and particle size on the hydrodynamic diffusion layer thickness.
    Andersson SBE; Frenning G; Alderborn G; Gråsjö J
    Eur J Pharm Biopharm; 2022 Nov; 180():1-10. PubMed ID: 36152951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of gliclazide immobilization into layered double hydroxide on drug release.
    Ambrogi V; Perioli L; Ciarnelli V; Nocchetti M; Rossi C
    Eur J Pharm Biopharm; 2009 Oct; 73(2):285-91. PubMed ID: 19539757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of a microcrystalline suspension formulation of Lys(B28)Pro(B29)-human insulin with ultralente properties.
    Richards JP; Stickelmeyer MP; Frank BH; Pye S; Barbeau M; Radziuk J; Smith GD; DeFelippis MR
    J Pharm Sci; 1999 Sep; 88(9):861-7. PubMed ID: 10479347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Added release time in diffusion/dissolution coupled release.
    Nuxoll E
    Int J Pharm; 2015 Oct; 494(1):195-204. PubMed ID: 26276252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
    Rao VM; Lin M; Larive CK; Southard MZ
    J Pharm Sci; 1997 Oct; 86(10):1132-7. PubMed ID: 9344170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mechanistic study of danazol dissolution in ionic surfactant solutions.
    Sun W; Larive CK; Southard MZ
    J Pharm Sci; 2003 Feb; 92(2):424-35. PubMed ID: 12532392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mathematical modeling of drug dissolution.
    Siepmann J; Siepmann F
    Int J Pharm; 2013 Aug; 453(1):12-24. PubMed ID: 23618956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissolution rate enhancement of gliclazide by ordered mixing.
    Saharan VA; Choudhury PK
    Acta Pharm; 2011 Sep; 61(3):323-34. PubMed ID: 21945911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolution of irregularly-shaped drug particles: mathematical modelling.
    Abrami M; Grassi M; Masiello D; Pontrelli G
    Eur J Pharm Biopharm; 2022 Aug; 177():199-210. PubMed ID: 35772613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.